Advertisement

Table of Contents

July 01, 1994; Volume 46,Issue 1

You have access
The gonadotrophin-releasing hormone receptor of alpha T3-1 pituitary cells regulates cellular levels of both of the phosphoinositidase C-linked G proteins, Gq alpha and G11 alpha, equally.
B H Shah and G Milligan

Molecular Pharmacology July 1994, 46 (1) 1-7;
You have access
Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
T M Filtz, Q Li, J L Boyer, R A Nicholas and T K Harden

Molecular Pharmacology July 1994, 46 (1) 8-14;
You have access
Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier

Molecular Pharmacology July 1994, 46 (1) 15-23;
You have access
Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking.
V Sánchez-Margalet, M Valle and R Goberna

Molecular Pharmacology July 1994, 46 (1) 24-29;
You have access
Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle.
M T Piascik, M S Smith, E E Soltis and D M Perez

Molecular Pharmacology July 1994, 46 (1) 30-40;
You have access
Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
M S Simonson and A Rooney

Molecular Pharmacology July 1994, 46 (1) 41-50;
You have access
Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
C P Silvia, G R King, T H Lee, Z Y Xue, M G Caron and E H Ellinwood

Molecular Pharmacology July 1994, 46 (1) 51-57;
You have access
Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
M K Ritke, W P Allan, C Fattman, N N Gunduz and J C Yalowich

Molecular Pharmacology July 1994, 46 (1) 58-66;
You have access
1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
S Kharbanda, Y Emoto, H Kisaki, A Saleem and D Kufe

Molecular Pharmacology July 1994, 46 (1) 67-72;
You have access
c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye

Molecular Pharmacology July 1994, 46 (1) 73-78;
You have access
Hepatocyte nuclear factor 3 is a major determinant of CYP2C6 promoter activity in hepatoma cells.
P M Shaw, M C Weiss and M Adesnik

Molecular Pharmacology July 1994, 46 (1) 79-87;
You have access
Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases.
M Chen, C Achkar and L J Gudas

Molecular Pharmacology July 1994, 46 (1) 88-96;
You have access
Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini

Molecular Pharmacology July 1994, 46 (1) 97-104;
You have access
Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
A Christopoulos and F Mitchelson

Molecular Pharmacology July 1994, 46 (1) 105-114;
You have access
The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro

Molecular Pharmacology July 1994, 46 (1) 115-121;
You have access
Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708.
B S Sachais and J E Krause

Molecular Pharmacology July 1994, 46 (1) 122-128;
You have access
Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
K M Partin, D K Patneau and M L Mayer

Molecular Pharmacology July 1994, 46 (1) 129-138;
You have access
Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
E Guillemare, E Honore, J De Weille, M Fosset, M Lazdunski and K Meisheri

Molecular Pharmacology July 1994, 46 (1) 139-145;
You have access
3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons.
M Park-Chung, F S Wu and D H Farb

Molecular Pharmacology July 1994, 46 (1) 146-150;
You have access
9-Aminoacridines act at a site different from that for Mg2+ in blockade of the N-methyl-D-aspartate receptor channel.
M E Nelson and E X Albuquerque

Molecular Pharmacology July 1994, 46 (1) 151-160;
You have access
Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors.
K Williams

Molecular Pharmacology July 1994, 46 (1) 161-168;
You have access
Cooperative interactions between general anesthetics and QX-222 within the pore of the acetylcholine receptor ion channel.
J P Dilger and A M Vidal

Molecular Pharmacology July 1994, 46 (1) 169-175;
You have access
The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
K Lee, S E Ozanne, I C Rowe, C N Hales and M L Ashford

Molecular Pharmacology July 1994, 46 (1) 176-185;
You have access
Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones.
P J Hayden, K E Free and C F Chignell

Molecular Pharmacology July 1994, 46 (1) 186-198;
You have access
Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.
M L Anthony, B C Sweatman, C R Beddell, J C Lindon and J K Nicholson

Molecular Pharmacology July 1994, 46 (1) 199-211;